Clinical Trials Browser

Phase 3 × OTHER × COVID-19 × Clear all

NCT04904536 2025-04-10

STRONGER

Phase 3 Active not recruiting

COVID-19, Lymphoma, Follicular, Neurologic Manifestations

NCT04534725 2023-08-24

C-SMART

Phase 3 Completed

COVID-19, Neoplasms

NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Phase 3 Unknown

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Phase 3 Withdrawn

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive